Home FOR AUTHORS Neoplasma 2016 Neoplasma Vol.63, No.1, p.150-157, 2016

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.63, No.1, p.150-157, 2016

Title: Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia
Author: H. Z. ZHAO, M. JIA, Z. B. LUO, Y. P. CHENG, X. J. XU, J. Y. ZHANG, S. S. LI, Y. M. TANG

Abstract: The prognostic value of the Musashi-2 (MSI2) gene has not yet been studied in childhood acute lymphoblastic leukemia (ALL). In our study, MSI2 mRNA levels of 119 childhood patients with newly-diagnosed ALL were examined and analyzed with regard to clinical characteristics and outcomes. ALL patients demonstrated significantly higher MSI2 mRNA levels than healthy controls. In addition, MSI2 mRNA levels were correlated with the disease status and IK6 mutation status. Survival analyses showed that higher MSI2 mRNA levels predicted worse outcomes in patients with childhood ALL. Moreover, in multivariate analyses, MSI2 mRNA overexpression retained its value as an independent risk factor for overall survival (OS), but not for event free survival (EFS). We conclude that high MSI2 mRNA level predicts adverse prognosis and seems to be useful as a novel prognostic factor for patients with childhood ALL.

Keywords: acute lymphoblastic leukemia, childhood, musashi-2, overall survival, prognosis
Published online: 16-Jan-2016
Year: 2016, Volume: 63, Issue: 1 Page From: 150, Page To: 157
doi:10.4149/neo_2016_018


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.